Searchable abstracts of presentations at key conferences in endocrinology

ea0050ep036 | Bone and Calcium | SFEBES2017

Intracranial Calcification

Misquita Lauren , Mason Claire , Ottaviani Diego , Rafique Aqqib , Mehta Sanjeev

A 58 year-old Polish lady was admitted to hospital after having had two tonic-clonic seizures. She reported a previous history of seizures but had been seizure-free for 10 years. In addition, she reported a 20 year history of hand spasms and perioral paraesthesia. As part of the investigation for seizures while she was living in Poland 10 years ago, CT head had shown bilateral basal ganglia calcification and on this basis she had been diagnosed with Fahr...

ea0066p74 | Pituitary | BSPED2019

STAT5B missense variant causing growth hormone deficiency with subclinical hypothyroidism and immune deficiency in a 13-year-old female: a case report

Verma Prashant Kumar , Mehta Sonalika , Chacham Swathi , Bhat Nowneet Kumar

Introduction: STAT5 proteins are components of the common growth hormone and interleukin-2 family of cytokine signaling pathway which is a critical molecule involved in growth hormone receptor (GHR) signal transduction, mediating the growth-promoting actions of the GHR. In addition to its role in GHR signal transduction, STAT5B is also involved in the immune system as an important mediator of interleukin-2 action and disruption of this signal transduction is responsible for T-...

ea0038p27 | Clinical biochemistry | SFEBES2015

Turn off the taps

Jones Sophie , Alexander Mariam , Hilton Christopher , Mehta Sanjeev

A 85-year-old man presented with a 2-week history of malaise, confusion and agitation and 4 weeks of polydipsia and polyuria, with water intake of 6 l/day. His past medical history included hypertension, congestive cardiac failure, and chronic kidney disease. On examination he was hypervolaemic. Initial investigations were as follows: serum sodium 115 mmol/l, potassium 4.6 mmol/l, urea 8.1 mmol/l (2.5–7.8), creatinine 138 μmol/l (66–112), serum osmolality 245 mO...

ea0034p279 | Pituitary | SFEBES2014

An unusual cause of pituitary apoplexy

Behary Preeshila , Townsey Gareth , Mehta Amrish , Meeran Karim

Hypopituitarism secondary to pituitary apoplexy is a rare but recognised complication following cardiac surgery but not cardiac arrest.We present a case report of acute pituitary apoplexy following a cardiac arrest on a background of sepsis. A 65-year-old gentleman presented with 3-day history of abdominal pain and vomiting. Of note, he underwent an appendicectomy 2 months earlier. He was septic and investigations revealed bowel perforation with faecal p...

ea0028p12 | Bone | SFEBES2012

A review of the multidisciplinary management of primary hyperparathyroidism in a district general hospital

Garg Anukul , Graja Tomasz , Mehta Gopal , Smith Simon , Jackson Alan

Aims and Objectives: We conducted a study of 71 patients with Primary Hyperparathyroidism being managed in a single site Joint Endocrine Service. We sought to review the adherence to current international guidelines in managing these cases, and the effectiveness of pre-operative localization to inform surgical options.Results: A total of 71 cases were reviewed, of whom 35 were managed conservatively and 36 underwent surgery. Every patient undergoing surg...

ea0010p20 | Clinical case reports/Governance | SFE2005

New onset diabetes associated with the atypical antipsychotic olanzapine

Mehta S , Hameed A , Patel D , Christen A , Mather H , Valabhji J

Schizophrenia is associated with higher risk of Type 2 diabetes. There are several reports of Type 2 diabetes presenting as diabetic ketoacidosis, particularly in young obese African-Caribbean subjects. We report 3 cases of new onset diabetes presenting with diabetic ketoacidosis (see Table 1) in African-Caribbean males treated with olanzapine for chronic schizophrenia.Table 1 Metabolic parameters on admissionCase</td...

ea0004p97 | Thyroid | SFE2002

Completing the loop: follow up and outcome of patients receiving radioactive iodine for thyrotoxicosis - the impact of a telephone clinic and adjunctive lithium

Mehta C , Murphy E , Stanley S , Meeran K

Significant delays in follow up and institution of thyroxine replacement for patients developing post-radioiodine (RAI) hypothyroidism were revealed by a three year retrospective audit. To reduce the incidence of undiagnosed early hypothyroidism and lengthy waits between outpatient visits, a telephone clinic was introduced in August 2000. Thyroid function tests are checked at 3, 6, 9 and 12 weeks post-treatment. Results are checked weekly by a Specialist Registrar. Patients wh...

ea0041ep281 | Clinical case reports - Pituitary/Adrenal | ECE2016

Managing a complex case of acromegaly – lessons to learn

Lye Yap Hsiu , Hatfield Emma , Martin Niamh , Assomull Ravi , Berry Stewart , Mehta Amrish , Falconer Alison , Mendoza Nigel , Meeran Karim , Mehta Sanjeev

Our 42-year-old patient presented with breathlessness and signs of congestive cardiac failure. Her ‘spade-like hands and acromegalic appearance’ were noted on the post-take round. She had headaches, orthopnoea and secondary amenorrhoea. She was a poorly controlled diabetic (so OGTT was not performed), anaemic, and previously had a thyroidectomy.Pituitary profile showed secondary hypogonadism, normoprolactinaemia and normal free T4 indicating ad...

ea0086p246 | Neuroendocrinology and Pituitary | SFEBES2022

A novel presentation of primary hyperparathyroidism for the Val804Met mutation

Yadav Jahnavi , Mehta Rubin , Avari Parizad , Freudenthal Bernard , Mulla Kaenat , Mistry Kieran , MacEacharn William , Cox Jeremy

Background: Multiple endocrine neoplasia type 2 (MEN2) is a group of pleomorphic syndromes which infer a susceptibility to several endocrine conditions. The RET Val804Met mutation is classified as a moderate-risk mutation for familial medullary thyroid cancer (MTC), without the other components of MEN2 syndromes. However, here we describe a rare case of a gentleman with RET p.V804M, presenting with primary hyperparathyroidism (PHPT) and no evidence of MTC.<p class="abstext...

ea0090ep1106 | Late Breaking | ECE2023

Diabetes treatment with dapagliflozin and its combinations: Insights from clinical practice

Mehta Ajit , Bafna Akshay , Goel Sandeep , Trivedi A.K. , Mishra Chandrakanta , Naik Preethi , Zalte Nitin , Sugumaran Amarnath

Background: Despite global guidelines recommending initiation of SGLT2i drugs like dapagliflozin in type 2 diabetes (T2DM) patients with cardiovascular (CV) or renal risk, its clinical translation is still lacking in India.Objective: To understand clinicians’ perspectives regarding the association of CV risk and T2DM in Indian patients, and the need for the use of combination therapies with dapagliflozin in T2DM patients, in Indian clinical practice...